HUP0202614A3 - Use of thienopyrimidines - Google Patents
Use of thienopyrimidinesInfo
- Publication number
- HUP0202614A3 HUP0202614A3 HU0202614A HUP0202614A HUP0202614A3 HU P0202614 A3 HUP0202614 A3 HU P0202614A3 HU 0202614 A HU0202614 A HU 0202614A HU P0202614 A HUP0202614 A HU P0202614A HU P0202614 A3 HUP0202614 A3 HU P0202614A3
- Authority
- HU
- Hungary
- Prior art keywords
- thienopyrimidines
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19943815A DE19943815A1 (en) | 1999-09-14 | 1999-09-14 | Use of thienopyrimidines |
PCT/EP2000/008258 WO2001019369A1 (en) | 1999-09-14 | 2000-08-24 | Use of thienopyrimidines |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0202614A2 HUP0202614A2 (en) | 2002-12-28 |
HUP0202614A3 true HUP0202614A3 (en) | 2004-11-29 |
Family
ID=7921854
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0202614A HUP0202614A3 (en) | 1999-09-14 | 2000-08-24 | Use of thienopyrimidines |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1212062A1 (en) |
JP (1) | JP2003509370A (en) |
KR (1) | KR20020026011A (en) |
CN (1) | CN1377271A (en) |
AR (1) | AR025645A1 (en) |
AU (1) | AU6703200A (en) |
BR (1) | BR0013957A (en) |
CA (1) | CA2387123A1 (en) |
CZ (1) | CZ2002818A3 (en) |
DE (1) | DE19943815A1 (en) |
HU (1) | HUP0202614A3 (en) |
MX (1) | MXPA02002746A (en) |
NO (1) | NO20021234D0 (en) |
PL (1) | PL353343A1 (en) |
RU (1) | RU2002107441A (en) |
SK (1) | SK3322002A3 (en) |
WO (1) | WO2001019369A1 (en) |
ZA (1) | ZA200202868B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2431147A1 (en) * | 2000-12-19 | 2002-06-27 | Merck Patent Gesellschaft Mit Beschraenkter Haftung | Pharmaceutical formulation comprising thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives (2) |
DE10135815A1 (en) * | 2001-07-23 | 2003-02-06 | Bayer Ag | Use of imidazo-triazinone derivative phosphodiesterase 5 inhibitors e.g. for treatment of cardiac insufficiency, psoriasis, diabetes, cancer, glaucoma, bladder disease, Parkinson's disease or pain |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5869486A (en) * | 1995-02-24 | 1999-02-09 | Ono Pharmaceutical Co., Ltd. | Fused pyrimidines and pyriazines as pharmaceutical compounds |
BR9708640B1 (en) * | 1996-04-12 | 2013-06-11 | irreversible tyrosine kinase inhibitors and pharmaceutical composition comprising them. | |
DE19644228A1 (en) * | 1996-10-24 | 1998-04-30 | Merck Patent Gmbh | Thienopyrimidines |
DE19819023A1 (en) * | 1998-04-29 | 1999-11-04 | Merck Patent Gmbh | Thienopyrimidines |
US5948911A (en) * | 1998-11-20 | 1999-09-07 | Cell Pathways, Inc. | Method for inhibiting neoplastic cells and related conditions by exposure to thienopyrimidine derivatives |
AU3453900A (en) * | 1999-03-30 | 2000-10-23 | Nippon Soda Co., Ltd. | Thienopyrimidine compounds and salts thereof and process for the preparation of the same |
-
1999
- 1999-09-14 DE DE19943815A patent/DE19943815A1/en not_active Withdrawn
-
2000
- 2000-08-24 CN CN00813731A patent/CN1377271A/en active Pending
- 2000-08-24 HU HU0202614A patent/HUP0202614A3/en unknown
- 2000-08-24 RU RU2002107441/14A patent/RU2002107441A/en not_active Application Discontinuation
- 2000-08-24 KR KR1020027003303A patent/KR20020026011A/en not_active Application Discontinuation
- 2000-08-24 AU AU67032/00A patent/AU6703200A/en not_active Abandoned
- 2000-08-24 WO PCT/EP2000/008258 patent/WO2001019369A1/en not_active Application Discontinuation
- 2000-08-24 EP EP00954650A patent/EP1212062A1/en not_active Withdrawn
- 2000-08-24 MX MXPA02002746A patent/MXPA02002746A/en not_active Application Discontinuation
- 2000-08-24 CA CA002387123A patent/CA2387123A1/en not_active Abandoned
- 2000-08-24 SK SK332-2002A patent/SK3322002A3/en unknown
- 2000-08-24 PL PL00353343A patent/PL353343A1/en unknown
- 2000-08-24 JP JP2001523002A patent/JP2003509370A/en active Pending
- 2000-08-24 BR BR0013957-2A patent/BR0013957A/en not_active IP Right Cessation
- 2000-08-24 CZ CZ2002818A patent/CZ2002818A3/en unknown
- 2000-09-13 AR ARP000104796A patent/AR025645A1/en not_active Application Discontinuation
-
2002
- 2002-03-13 NO NO20021234A patent/NO20021234D0/en not_active Application Discontinuation
- 2002-04-11 ZA ZA200202868A patent/ZA200202868B/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP1212062A1 (en) | 2002-06-12 |
ZA200202868B (en) | 2003-11-26 |
HUP0202614A2 (en) | 2002-12-28 |
JP2003509370A (en) | 2003-03-11 |
RU2002107441A (en) | 2003-11-20 |
CN1377271A (en) | 2002-10-30 |
PL353343A1 (en) | 2003-11-17 |
AU6703200A (en) | 2001-04-17 |
NO20021234L (en) | 2002-03-13 |
BR0013957A (en) | 2002-05-21 |
MXPA02002746A (en) | 2002-10-23 |
NO20021234D0 (en) | 2002-03-13 |
DE19943815A1 (en) | 2001-03-15 |
WO2001019369A1 (en) | 2001-03-22 |
SK3322002A3 (en) | 2002-07-02 |
AR025645A1 (en) | 2002-12-04 |
KR20020026011A (en) | 2002-04-04 |
CZ2002818A3 (en) | 2002-06-12 |
CA2387123A1 (en) | 2001-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL361277A1 (en) | Use of thienopyrimidines | |
PL355101A1 (en) | Use of h1 | |
IL145995A0 (en) | Use | |
GB9913536D0 (en) | Use | |
PL351822A1 (en) | Thienopyrimidines as phosphodiesterase inhibitors | |
GB9900227D0 (en) | Use of a composition | |
EG22530A (en) | Preparation of substituted piperidin-4-ones | |
EP1218407A4 (en) | Uses of kappa-conotoxin pviia | |
PL352409A1 (en) | Derivatives of 1-trifluorometyl-4-hydroxy-7-piperidinyl-aminomethylochromane | |
GB9925634D0 (en) | Modification of plants | |
PL350963A1 (en) | Use of arylalkanoylpyridazines | |
HUP0202614A3 (en) | Use of thienopyrimidines | |
GB9919971D0 (en) | Use | |
GB9910667D0 (en) | New use of citreamicins | |
GB9926014D0 (en) | Measurement of objects | |
EP1230928A4 (en) | Use of peptide | |
HU9900075V0 (en) | Sepulchre consists of elements | |
TW422400U (en) | Improvement of transformer | |
GB9925382D0 (en) | Preparation of sulphides | |
TW468411U (en) | Structure of cardcase | |
TW394123U (en) | Structure of emery-roller | |
GB9920641D0 (en) | Gnosis - The game of understanding | |
TW399438U (en) | Improved structure of bedhead | |
TW389046U (en) | Structure of hairgrip combinations | |
GB9921062D0 (en) | Use of cholestrol-lowering agent |